Moderna said Wednesday its updated fall COVID booster, which is pending approval from the Food and Drug Administration, performed well against the highly mutated BA.2.86 variant.
Moderna said Wednesday its updated fall COVID booster, which is pending approval from the Food and Drug Administration, performed well against the highly mutated BA.2.86 variant.
Leave A Comment